163 related articles for article (PubMed ID: 11241755)
1. Genetic events associated with arsenic-induced malignant transformation: applications of cDNA microarray technology.
Chen H; Liu J; Merrick BA; Waalkes MP
Mol Carcinog; 2001 Feb; 30(2):79-87. PubMed ID: 11241755
[TBL] [Abstract][Full Text] [Related]
2. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
[TBL] [Abstract][Full Text] [Related]
3. Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis.
Chen H; Li S; Liu J; Diwan BA; Barrett JC; Waalkes MP
Carcinogenesis; 2004 Sep; 25(9):1779-86. PubMed ID: 15073043
[TBL] [Abstract][Full Text] [Related]
4. Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation.
Benbrahim-Tallaa L; Waterland RA; Styblo M; Achanzar WE; Webber MM; Waalkes MP
Toxicol Appl Pharmacol; 2005 Aug; 206(3):288-98. PubMed ID: 16039940
[TBL] [Abstract][Full Text] [Related]
5. Further studies on aberrant gene expression associated with arsenic-induced malignant transformation in rat liver TRL1215 cells.
Liu J; Benbrahim-Tallaa L; Qian X; Yu L; Xie Y; Boos J; Qu W; Waalkes MP
Toxicol Appl Pharmacol; 2006 Nov; 216(3):407-15. PubMed ID: 16876216
[TBL] [Abstract][Full Text] [Related]
6. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression.
Zhao CQ; Young MR; Diwan BA; Coogan TP; Waalkes MP
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10907-12. PubMed ID: 9380733
[TBL] [Abstract][Full Text] [Related]
7. Low-level arsenite induced gene expression in HEK293 cells.
Zheng XH; Watts GS; Vaught S; Gandolfi AJ
Toxicology; 2003 May; 187(1):39-48. PubMed ID: 12679051
[TBL] [Abstract][Full Text] [Related]
8. Application of cDNA microarray to the study of arsenic-induced liver diseases in the population of Guizhou, China.
Lu T; Liu J; LeCluyse EL; Zhou YS; Cheng ML; Waalkes MP
Toxicol Sci; 2001 Jan; 59(1):185-92. PubMed ID: 11134558
[TBL] [Abstract][Full Text] [Related]
9. MRNA and miRNA expression patterns associated to pathways linked to metal mixture health effects.
Martínez-Pacheco M; Hidalgo-Miranda A; Romero-Córdoba S; Valverde M; Rojas E
Gene; 2014 Jan; 533(2):508-14. PubMed ID: 24080485
[TBL] [Abstract][Full Text] [Related]
10. Acquisition of apoptotic resistance in arsenic-induced malignant transformation: role of the JNK signal transduction pathway.
Qu W; Bortner CD; Sakurai T; Hobson MJ; Waalkes MP
Carcinogenesis; 2002 Jan; 23(1):151-9. PubMed ID: 11756236
[TBL] [Abstract][Full Text] [Related]
11. Transplacental arsenic exposure produced 5-methylcytosine methylation changes and aberrant microRNA expressions in livers of male fetal mice.
Liu J; Gunewardena S; Yue Cui J; Klaassen CD; Chorley BN; Corton JC
Toxicology; 2020 Apr; 435():152409. PubMed ID: 32068019
[TBL] [Abstract][Full Text] [Related]
12. Inorganic Arsenic-induced cellular transformation is coupled with genome wide changes in chromatin structure, transcriptome and splicing patterns.
Riedmann C; Ma Y; Melikishvili M; Godfrey SG; Zhang Z; Chen KC; Rouchka EC; Fondufe-Mittendorf YN
BMC Genomics; 2015 Mar; 16(1):212. PubMed ID: 25879800
[TBL] [Abstract][Full Text] [Related]
13. Transplacental exposure to inorganic arsenic at a hepatocarcinogenic dose induces fetal gene expression changes in mice indicative of aberrant estrogen signaling and disrupted steroid metabolism.
Liu J; Xie Y; Cooper R; Ducharme DM; Tennant R; Diwan BA; Waalkes MP
Toxicol Appl Pharmacol; 2007 May; 220(3):284-91. PubMed ID: 17350061
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic effects of low-level sodium arsenite exposure on human liver HepaRG cells.
Tryndyak VP; Borowa-Mazgaj B; Steward CR; Beland FA; Pogribny IP
Arch Toxicol; 2020 Dec; 94(12):3993-4005. PubMed ID: 32844245
[TBL] [Abstract][Full Text] [Related]
15. Effect of glutathione depletion and metallothionein gene expression on arsenic-induced cytotoxicity and c-myc expression in vitro.
Shimizu M; Hochadel JF; Fulmer BA; Waalkes MP
Toxicol Sci; 1998 Oct; 45(2):204-11. PubMed ID: 9848127
[TBL] [Abstract][Full Text] [Related]
16. Silencing KRAS overexpression in arsenic-transformed prostate epithelial and stem cells partially mitigates malignant phenotype.
Ngalame NN; Tokar EJ; Person RJ; Waalkes MP
Toxicol Sci; 2014 Dec; 142(2):489-96. PubMed ID: 25273566
[TBL] [Abstract][Full Text] [Related]
17. Transformation by inorganic arsenic compounds of normal Syrian hamster embryo cells into a neoplastic state in which they become anchorage-independent and cause tumors in newborn hamsters.
Takahashi M; Barrett JC; Tsutsui T
Int J Cancer; 2002 Jun; 99(5):629-34. PubMed ID: 12115494
[TBL] [Abstract][Full Text] [Related]
18. Characterization of gene expression changes associated with MNNG, arsenic, or metal mixture treatment in human keratinocytes: application of cDNA microarray technology.
Bae DS; Hanneman WH; Yang RS; Campain JA
Environ Health Perspect; 2002 Dec; 110 Suppl 6(Suppl 6):931-41. PubMed ID: 12634122
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-21, up-regulated by arsenite, directs the epithelial-mesenchymal transition and enhances the invasive potential of transformed human bronchial epithelial cells by targeting PDCD4.
Luo F; Ji J; Liu Y; Xu Y; Zheng G; Jing J; Wang B; Xu W; Shi L; Lu X; Liu Q
Toxicol Lett; 2015 Jan; 232(1):301-9. PubMed ID: 25445583
[TBL] [Abstract][Full Text] [Related]
20. miR-145 via targeting ERCC2 is involved in arsenite-induced DNA damage in human hepatic cells.
Wei S; Xue J; Sun B; Zou Z; Chen C; Liu Q; Zhang A
Toxicol Lett; 2018 Oct; 295():220-228. PubMed ID: 29705342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
